← Leaderboards
Samuel J Danishefsky
Sloan-Kettering Institute For Cancer Res
$25,022,733
Attributed
$27,521,803
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–15$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$27,521,803 · 9
By mechanism
R01$20,432,422 · 7
R37$6,898,090 · 1
R21$191,291 · 1
Top collaborators
- Jason S Lewis4 shared
- Govind Ragupathi4 shared
- Philip O. Livingston3 shared
Others in their field
Top investigators on “Chemical Synthesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$156,891,547
- David H Walker · University Of Texas Medical Br Galveston$61,066,312
- Jay D Keasling · University Of California-Berkeley$45,089,571
- Marc A Hillmyer · University Of Minnesota-Twin Cities$43,647,280
- Huw M Davies · Suny At Buffalo$42,517,196
- Harry B Gray · California Institute Of Technology$40,481,419
Research focus
Chemical SynthesisLaboratoriesProgramsBiologicalMethodologyBiological FactorsBaseSmall MoleculeStructureOrganic SynthesisComplexInterestGrantGlycoproteinsEvaluationAnalogCarbohydratesVaccinesUrsidae FamilyCategoriesProteinsChemistryErythropoietinInsight
Grant awards (51)
New Synthetic Reactions to Reach Bioactive Proteins$426,480
R01 · FY2015 · GM · contact PI
Synthesis of Antitumor Natural Products$379,518
R01 · FY2015 · CA · contact PI
Development of D-Peptide Inhibitors of Oncogenic KRAS Mutants$191,291
R21 · FY2015 · CA · contact PI
Synthesis Directed Toward Therapeutic Agents$585,282
R01 · FY2014 · GM · contact PI
New Synthetic Reactions to Reach Bioactive Proteins$426,480
R01 · FY2014 · GM · contact PI
Synthesis of Antitumor Natural Products$368,132
R01 · FY2014 · CA · contact PI
Novel Adjuvant Discovery in Vaccine Therapy$819,424
R01 · FY2013 · AI
Synthesis Directed Toward Therapeutic Agents$564,797
R01 · FY2013 · GM · contact PI
Synthesis of Antitumor Natural Products$356,747
R01 · FY2013 · CA · contact PI
Novel Adjuvant Discovery in Vaccine Therapy$871,728
R01 · FY2012 · AI
Synthesis Directed Toward Therapeutic Agents$585,280
R01 · FY2012 · GM · contact PI
New Synthetic Reactions For Active Principles$515,679
R01 · FY2012 · HL · contact PI
Synthesis of Antitumor Natural Products$379,518
R01 · FY2012 · CA · contact PI
Novel Adjuvant Discovery in Vaccine Therapy$869,286
R01 · FY2011 · AI
Synthesis of Antitumor Natural Products$771,834
R37 · FY2011 · CA · contact PI
Synthesis of Antiinfective Agents$598,892
R01 · FY2011 · CA · contact PI
New Synthetic Reactions For Active Principles$447,778
R01 · FY2011 · HL · contact PI
Synthesis of Antiinfective Agents$904,868
R01 · FY2010 · CA · contact PI
Novel Adjuvant Discovery in Vaccine Therapy$862,703
R01 · FY2010 · AI
Synthesis of Antitumor Natural Products$795,705
R37 · FY2010 · CA · contact PI
New Synthetic Reactions For Active Principles$450,576
R01 · FY2010 · HL · contact PI
Synthesis of Antitumor Natural Products$772,528
R37 · FY2009 · CA · contact PI
Synthesis of Antiinfective Agents$607,496
R01 · FY2009 · CA · contact PI
New Synthetic Reactions For Active Principles$447,811
R01 · FY2009 · HL · contact PI
Synthesis of Antitumor Natural Products$750,028
R37 · FY2008 · CA · contact PI
Synthesis of Antiinfective Agents$589,972
R01 · FY2008 · CA · contact PI
NEW SYNTHESIS OF REACTIONS FOR ACTIVE PRINCIPLES$449,564
R01 · FY2008 · HL · contact PI
Synthesis of Antitumor Natural Products$742,935
R37 · FY2007 · CA · contact PI
Synthesis of Antiinfective Agents$558,006
R01 · FY2007 · CA · contact PI
NEW SYNTHESIS OF REACTIONS FOR ACTIVE PRINCIPLES$445,378
R01 · FY2007 · HL · contact PI
Synthesis of Antitumor Natural Products$637,684
R37 · FY2006 · CA · contact PI
Synthesis of Antiinfective Agents$558,992
R01 · FY2006 · CA · contact PI
NEW SYNTHESIS OF REACTIONS FOR ACTIVE PRINCIPLES$445,315
R01 · FY2006 · HL · contact PI
Synthesis of Antitumor Natural Products$634,010
R37 · FY2005 · CA
Synthesis of Antiinfective Agents$507,195
R01 · FY2005 · CA
NEW SYNTHESIS OF REACTIONS FOR ACTIVE PRINCIPLES$442,752
R01 · FY2005 · HL
Synthesis of Antitumor Natural Products$615,543
R37 · FY2004 · CA
Synthesis of Antiinfective Agents$493,370
R01 · FY2004 · CA
NEW SYNTHETIC REACTIONS FOR ACTIVE PRINCIPLES$384,938
R01 · FY2004 · HL
Synthesis of Antitumor Natural Products$597,615
R37 · FY2003 · CA
Synthesis of Antiinfective Agents$477,581
R01 · FY2003 · CA
NEW SYNTHETIC REACTIONS FOR ACTIVE PRINCIPLES$384,938
R01 · FY2003 · HL
Synthesis of Antitumor Natural Products$580,208
R37 · FY2002 · CA
SYNTHESIS OF ANTIINFECTIVE AGENTS$415,563
R01 · FY2002 · AI
NEW SYNTHETIC REACTIONS FOR ACTIVE PRINCIPLES$384,938
R01 · FY2002 · HL
SYNTHESIS OF ANTITUMOR NATURAL PRODUCTS$438,551
R01 · FY2001 · CA
SYNTHESIS OF ANTIINFECTIVE AGENTS$403,459
R01 · FY2001 · AI
NEW SYNTHETIC REACTIONS FOR ACTIVE PRINCIPLES$382,939
R01 · FY2001 · HL
SYNTHESIS OF ANTITUMOR NATURAL PRODUCTS$427,512
R01 · FY2000 · CA
SYNTHESIS OF ANTIINFECTIVE AGENTS$391,709
R01 · FY2000 · AI
NEW SYNTHETIC REACTIONS FOR ACTIVE PRINCIPLES$381,275
R01 · FY2000 · HL